Compound information
- Natural Products
- ZC1846671
- Molecular Formula
- C19H30N2O4S
- Molecular Weight
- 382.19262844 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-[4-[(1R)-1-methylpropyl]phenyl]sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C19H30N2O4S/c1-6-15(2)16-7-9-17(10-8-16)26(23,24)21-13-11-20(12-14-21)18(22)25-19(3,4)5/h7-10,15H,6,11-14H2,1-5H3/t15-/m1/s1
- InChI Key
- QLQPWQOARWMQDI-OAHLLOKOSA-N
- SMILES
- CC[C@@H](C)c1ccc(S(=O)(=O)N2CCN(C(=O)OC(C)(C)C)CC2)cc1
- Source
- ZINC000017078164
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 26 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 3.99 |
LogS | -5.103 | LogD | 3.898 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.058 | Pgp substrate | 0.135 |
HIA | 0.969 | F20 % | 0.985 |
F30 % | 0.969 | Caco-2 | -4.454 |
MDCK | -4.855 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.395 | PPB | 90.014 |
VD | 1.578 | Fu | 0.864 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.064 | CYP1A2 substrate | 0.407 |
CYP2A6 substrate | 0.707 | CYP2B6 substrate | 0.665 |
CYP2C19 inhibitor | 0.852 | CYP2C19 substrate | 0.838 |
CYP2C8 substrate | 0.628 | CYP2C9 inhibitor | 0.626 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.221 |
CYP2D6 substrate | 0.933 | CYP2E1 substrate | 0.717 |
CYP3A4 inhibitor | 0.683 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.225 | CL | 8.014 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.969 | Hepatotoxicity | 0.74 |
Mutagenicity | 0.121 | Rat Oral Acute Toxicity | 0.212 |
FDAMDD | 0.114 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.822 | Eye Corrosion | 0.007 |
Eye Irritation | 0.017 | Respiratory Toxicity | 0.693 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.809 | IGC50 | 3.882 |
LC50FM | 3.131 | LC50DM | 3.216 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.194 | NR-AR-LBD | 0.264 |
NR-AhR | 0.011 | NR-Aromatase | 0.778 |
NR-ER | 0.228 | NR-ER-LBD | 0.429 |
NR-PPAR-gamma | 0.13 | SR-ARE | 0.757 |
SR-ATAD5 | 0.369 | SR-HSE | 0.086 |
SR-MMP | 0.041 | SR-p53 | 0.035 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.